Home About Us Contact Us

 

Table of Content - Volume 7 Issue 2 - August 2017


 

Relationship between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease

 

Sham Kamble1*, Manpreet Singh2

 

1Associate Professor, 2Jr. Resident, Department of Medicine, Government Grant Medical College And JJ Group Of Hospitals, JJ Marg, Mumbai-400008, Maharashtra, INDIA.

Email: drspk5384@gmail.com

 

REFERENCES

  1. Fabbri LM, Luppi F, Beghé B, et al. Complex chronic comorbidities of COPD. EurRespir J 2008; 31:204–212.
  2. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J RespirCrit Care Med 2012; 186:155–161.
  3. Lainscak M, Cleland JG, Lenzen MJ, et al. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 2007; 9:292–299.
  4. Hawkins NM, Petrie MC, Jhund PS, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 2009; 11: 130–139.
  5. Huang YS, Feng YC, Zhang J, et al. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients. Clinical Interventions in Aging 2015; 10 81–87.
  6. Boussuges A, Pinet C, Molenat F, et al. Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Dop­pler study. Am J RespirCrit Care Med 2000; 162(2 pt 1):670–675.
  7. Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J RespirCrit Care Med 2008; 177:743–751.
  8. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. EurRespir J 2009; 33:1165–85. 
  9. Schünemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118:656-664.
  10. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk In Communities Study. Am J Epidemiol 2003; 158:1171-1181.
  11. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with pre­served ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflamma­tion. J Am CollCardiol 2013; 62:263–271.
  12. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J RespirCrit Care Med 2007; 176:1200–1207.
  13. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. EurRespir J 2008; 32:1371–1385.
  14. Chatila WM, Thomashow BM, Minai OA, et al. Comor­bidities in chronic obstructive pulmonary disease. Proc Am ThoracSoc 2008; 5:549–555.
  15. Falk JA, Kadiev S, Criner GJ, et al. Cardiac disease in chronic obstructive pulmonary disease. Proc Am ThoracSoc 2008; 5:543–548.
  16. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010; 137:39S–51S.
  17. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531–1536.
  18. MacNee W. Pathophysiology of corpulmonale in chronic obstructive pulmonary disease. Am J RespirCrit Care Med 1994; 150:833–852.
  19. Barbera` JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. EurRespir J 2003; 21:892–905.
  20. Jorgensen K, Muller MF, Nel J, et al. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest 2007; 131:1050–7.
  21. Wahsh RA, Ahmed MK, Yaseen RI. Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease with or without pulmonary hypertension. Egyptian Journal of Chest Diseases and Tuberculosis 2013; 62:575–582.
  22. Rutten FH, Cramer MJ, Grobbee DE, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26(18):1887-94.